ICM
HMHC

Invenomic Capital Management’s Houghton Mifflin Harcourt Company HMHC Stock Holding History

Invenomic Capital Management’s Portfolio HMHC Stock Details HMHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-123,119
Closed -$410K – 170
2020
Q4 		$410K Buy
+123,119
New +$367K 0.1% 106

Other funds holding HMHC

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.13B AUM 53.44% 1-Year Est. Return
ECM
Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

Invenomic Capital Management's HMHC Position: Q1 2021 in Review

Invenomic Capital Management sold out of Houghton Mifflin Harcourt Company (HMHC) in Q1 2021, closing a stake of 123,119 shares — an estimated $410K sold.

Invenomic Capital Management first reported a position in HMHC in Q4 2020 and held it in 1 quarter. The position peaked at $410K in Q4 2020. 129 funds tracked by Wall St. Rank hold HMHC as of Q1 2021.

  • Invenomic Capital Management reported no remaining Houghton Mifflin Harcourt Company position as of Q1 2021 after selling out during the quarter.
  • Invenomic Capital Management sold 123,119 Houghton Mifflin Harcourt Company shares in Q1 2021, an estimated $410K.
  • Invenomic Capital Management first reported a position in Houghton Mifflin Harcourt Company in Q4 2020 and held it in 1 quarter.
  • Invenomic Capital Management's Houghton Mifflin Harcourt Company position peaked at $410K in Q4 2020.
  • 129 funds tracked by Wall St. Rank held Houghton Mifflin Harcourt Company as of Q1 2021.

Based on Invenomic Capital Management's 13F filing for Q1 2021, filed 13 May 2021.